Abstract
“Complementary and alternative medicine (CAM) is used to described a wide variety of methods, procedures, substances, and medical systems. Complementary medicine is practiced in addition to conventional medicine, whereas alternative medicine is intended to replace standard methods. For this reason, alternative methods are generally rejected by the scientific community.”
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Langhorst J (2006) Gastrointestinale Erkrankungen: Chronisch entzündliche Darmerkrankungen. In: Dobos G, Deuse U, Michalsen A (eds) Chronische Erkrankungen integrativ. Elsevier, Urban & Fischer, Amsterdam
Langhorst J, Anthonisen IB, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, Dobos GJ (2005) Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in German patients with inflammatory bowel disease: results from a national survey. Inflamm Bowel Dis 11(3):287–295
Suggested Readings
Langhorst J, Wulfert H, Lauche R, Klose P, Cramer H, Dobos GJ, Korzenik J (2014) Systematic review on complementary and alternative medicine treatments in inflammatory bowel diseases. J Crohn’s Colitis 9(1):86–106
Wieland LS, Manheimer E, Berman BM (2011) Development and classification of an operational definition of complementary and alternative medicine for the Cochrane collaboration. Altern Ther Health Med 17(2):50–59
Langhorst J, Anthonisen I, Steder-Neukamm U, Lüdtke R, Spahn G, Michalsen A, Dobos GJ (2007) Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: perceived stress is a potential indicator for CAM use. Complement Ther Med 15(1):30–37
Fernandez-Banares F, Hinojosa J, Sanchez-Lombrana JL et al (1999) Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis. Spanish Group for the Study of Crohn’s Disease and Ulcerative Colitis (GETECCU). Am J Gastroenterol 94:427–433
Gupta I, Parihar A, Malhotra P et al (2001) Effects of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med 67:391–395
Gupta I, Parihar A, Malhotra P et al (1997) Effects of Boswellia serrata gum resin in patients with ulcerative colitis. Eur J Med Res 2:37–43
Gerhardt H, Seifert F, Buvari P et al (2001) Therapy of active Crohn disease with Boswellia serrata extract H15. Z Gastroenterol 39:11–17
Holtmeier W, Zeuzem S, Preiss J et al (2011) Randomized, placebo-controlled, double-blind trial of Boswellia serrata in maintaining remission of Crohn’s disease: good safety profile but lack of efficacy. Inflamm Bowel Dis 17(2):573–582
Langhorst J, Varnhagen I, Schneider SB, Albrecht U, Rueffer A, Stange R, Michalsen A, Dobos GJ (2013a) Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared to mesalazine in maintaining remission in ulcerative colitis – a double-blind, double dummy study. Aliment Pharmacol Ther 38(5):490–500
Biedermann L, Mwinyi J, Scharl M et al (2013) Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis - an open pilot study. J Crohns Colitis 7(4):271–279
Huber R, Ditfurth AV, Amann F et al (2007) Tormentil for active ulcerative colitis: an open-label, dose-escalating study. J Clin Gastroenterol 41:834–838
Hanai H, Iida T, Takeuchi K et al (2006) Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 4:1502–1506
Lang A, Salomon N, Wu JCY et al (2015) Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol 13:1444–1449
Omer B, Krebs S, Omer H, Noor TO (2007) Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study. Phytomedicine 14(2–3):87–95
Krebs S, Omer TN, Omer B (2010) Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn’s disease - a controlled clinical trial. Phytomedicine 17(5):305–309
Langmead L, Feakins RM, Goldthorpe S et al (2004) Randomized, double-blind, placebo-controlled trial of oral aloe vera gel for active ulcerative colitis. Aliment Pharmacol Ther 19:739–747
Ben-Arye E, Goldin E, Wengrower D et al (2002) Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol 37:444–449
Tang T, Targan SR, Li ZS, Xu C, Byers VS, Sandborn WJ (2011) Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis - a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther 33(2):194–202
Sandborn WJ, Targan SR, Byers VS, Rutty DA, Mu H, Zhang X, Tang T (2013) Andrographis paniculata extract (HMPL-004) for active ulcerative colitis. Am J Gastroenterol 108:90–98
Naftali T, Lev LB, Yablecovitch D, Half E, Konikoff FM (2011) Treatment of Crohn’s disease with cannabis: an observational study. Isr Med Assoc J 13(8):455–458
Naftali T, Bar-Lev Schleider L, Dotan I et al (2013) Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study. Clin Gastroenterol Hepatol 11(10):1276–1280
Joos S, Brinkhaus B, Maluche C et al (2004) Acupuncture and moxibustion in the treatment of active Crohn’s disease: a randomized controlled study. Digestion 69:131–139
Joos S, Wildau N, Kohnen R et al (2006) Acupuncture and moxibustion in the treatment of ulcerative colitis: a randomized controlled study. Scand J Gastroenterol 41:1056–1063
Ji J, Lu Y, Liu H et al (2013) Acupuncture and moxibustion for inflammatory bowel diseases: a systematic review and meta-analysis of randomized controlled trials. Evid Based Complement Alternat Med 2013:158352
Lee DH, Kim JI, Lee MS et al (2010) Moxibustion for ulcerative colitis: a systematic review and meta-analysis. BMC Gastroenterol 10:36
Elsenbruch S, Langhorst J, Popkirowa K et al (2005) Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 74:277–287
Jedel S, Hoffman A, Merriman P et al (2014) A randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis. Digestion 89:142–155
Berrill JW, Sadlier M, Hood K et al (2014) Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels. J Crohns Colitis 8(9):945–955
Levenstein S, Prantera C, Varvo V, Scribano ML, Berto E, Andreoli A, Luzi C (1994) Psychological stress and disease activity in ulcerative colitis: a multidimensional cross-sectional study. Am J Gastroenterol 89(8):1219–1225
Levenstein S, Prantera C, Varvo V et al (2000) Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 95:1213–1220
Langhorst J, Hofstetter A, Wolfe F et al (2013b) Short-term stress, but not mucosal healing nor depression was predictive for the risk of relapse in patients with ulcerative colitis: a prospective 12-month follow-up study. Inflamm Bowel Dis 19:2380–2386
Mizrahi MC, Reicher-Atir R, Levy S, Haramati S, Wengrower D, Israeli E, Goldin E (2012) Effects of guided imagery with relaxation training on anxiety and quality of life among patients with inflammatory bowel disease. Psychol Health 27:1463–1479
Keefer L, Taft TH, Kiebles JL, Martinovich Z, Barrett TA, Palsson OS (2013) Gut-directed hypnotherapy significantly augments clinical remission in quiescent ulcerative colitis. Aliment Pharmacol Ther 38:761–771
Sonnenberg A (1990) Occupational mortality of inflammatory bowel diseases. Digestion 46(1):10–18
Khalili H, Ananthakrishnan AN, Konijeti GG et al (2013) Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses’ Health Study cohorts. BMJ 347:f6633. https://doi.org/10.1136/bmj.f6633
Nunes T, Etchevers MJ, Domènech E, Tobacco-Eneida Study Group of GETECCU et al (2013) Smoking does influence disease behaviour and impacts the need for therapy in Crohn's disease in the biologic era. Aliment Pharmacol Ther 38(7):752–760
Cramer H, Schafer M, Schols M et al (2017) Randomised clinical trial: yoga vs written self-care advice for ulcerative colitis. Aliment Pharmacol Ther 45(11):1379–1389
Schneider A, Streitberger K, Joos S (2007) Acupuncture treatment in gastrointestinal diseases: a systematic review. World J Gastroenterol 13(25):3417–3424
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Langhorst, J. (2019). Complementary Therapies. In: Sturm, A., White, L. (eds) Inflammatory Bowel Disease Nursing Manual. Springer, Cham. https://doi.org/10.1007/978-3-319-75022-4_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-75022-4_18
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75021-7
Online ISBN: 978-3-319-75022-4
eBook Packages: MedicineMedicine (R0)